Cargando…
Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database
BACKGROUND: Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we sought to document current practices in the frequency, di...
Autores principales: | Caroff, Stanley N., Roberts, Christopher B., Rosenberg, Henry, Tobin, Joseph R., Watt, Stacey, Mashman, Darlene, Riazi, Sheila, Berkowitz, Rosalind M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484236/ https://www.ncbi.nlm.nih.gov/pubmed/36123618 http://dx.doi.org/10.1186/s12871-022-01841-z |
Ejemplares similares
-
Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice
por: Azam, Mohammed Ali, et al.
Publicado: (2021) -
Malignant hyperthermia and dantrolene sodium
por: Kim, Ha Jung, et al.
Publicado: (2019) -
Congenital hypermetabolism and uncoupled oxidative phosphorylation
por: Ganetzky, Rebecca D., et al.
Publicado: (2022) -
Current clinical application of dantrolene sodium
por: Yang, Hong Seuk, et al.
Publicado: (2023) -
Malignant hyperthermia when dantrolene is not readily available
por: Gong, Xiaodan
Publicado: (2021)